Table 1.
Patient characteristics
| Number of patients, the entire group | n = 104 |
|---|---|
| Age, years | 71 ± 7 |
| Male, n (%) | 66 (63) |
| Body mass index, kg/m2 | 21.7 ± 3.5 |
| Hypertension, n (%) | 74 (71) |
| Diabetes mellitus, n (%) | 39 (38) |
| Dyslipidemia, n (%) | 47 (45) |
| Prior myocardial infarction, n (%) | 10 (10) |
| Prior coronary revascularization, n (%) | 29 (28) |
| Prior stroke, n (%) | 15 (14) |
| Smoking history, n (%) | 35 (34) |
| Systolic blood pressure, mm Hg | 138 ± 22 |
| Heart rate, bpm | 75 ± 12 |
| LVEF <50%, n (%) | 20 (19) |
| baPWV, cm/s | 2262 ± 748 |
| Abnormal ABI, n (%) | 31 (30) |
| Medication | |
| ACE‐I/ARB, n (%) | 42 (40) |
| Calcium channel blocker, n (%) | 52 (50) |
| Beta blocker, n (%) | 29 (28) |
| Statin, n (%) | 14 (13) |
| Aspirin, n (%) | 48 (46) |
| Laboratory test | |
| Hemoglobin A1c, % | 5.5 ± 0.9 |
| Hemoglobin, g/dL | 10.8 ± 1.1 |
| HDL‐cholesterol, mg/dL | 49 ± 12 |
| LDL‐cholesterol, mg/dL | 87 ± 29 |
| BNP, pg/mL | 368.8 (164.2‐749.8) |
| hs‐TnT, ng/mL | 0.063 (0.042‐0.095) |
| hs‐CRP, mg/dL | 0.08 (0.032‐0.258) |
Note: Variables are presented as number (%), mean ± SD, or median (IQR). The outcome measures of baPWV and biomarkers including BNP, hs‐cTnT, and hs‐CRP were divided into tertiles of the entire group (n = 104).
Abbreviations: ABI, ankle‐brachial index; ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ba‐PWV, brachial‐ankle‐pulse wave velocity; BNP, brain‐natriuretic protein; HDL, high‐density lipoprotein; hs‐CRP, high‐sensitive C‐reactive protein; hs‐cTnT, high‐sensitive cardiac troponin T; hs‐TnT, high‐sensitive troponin T; IQR, interquartile range; LDL, low‐density lipoprotein; LVEF, left ventricular ejection fraction.